col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


55 Results       Page 1

 [1] 
MDPI AG: Pharmaceutics
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―28 Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression Khushwant S. Bhullar, Manal A. Nael, Khaled M. Elokely, Steven J. Drews, Jianping Wu
2 [GO] 2022―Sep―26 Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study Assem Ashimova, Askhat Myngbay, Sergey Yegorov, Baurzhan Negmetzhanov, Irina Kadyrova, Angelina Yershova, et al. (+3)
3 [GO] 2022―Sep―21 2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19 Francesca Cantini, Emanuele Andreano, Ida Paciello, Veronica Ghini, Francesco Berti, Rino Rappuoli, Lucia Banci
4 [GO] 2022―Sep―08 The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences Minela Aida Maranduca, Daniela Maria Tanase, Cristian Tudor Cozma, Nicoleta Dima, Andreea Clim, Alin Constantin Pinzariu, et al. (+2)
5 [GO] 2022―Sep―07 Reply to Zandi, M.; Soltani, S. Comment on “Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502” Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, et al. (+8)
6 [GO] 2022―Sep―07 Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502 Milad Zandi, Saber Soltani
7 [GO] 2022―Aug―31 Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients Verena Schöning, Felix Hammann
8 [GO] 2022―Aug―01 Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem Maria Sanz Codina, Milo Gatti, Carla Troisi, Giacomo Fornaro, Zeno Pasquini, Filippo Trapani, et al. (+4)
9 [GO] 2022―Jul―22 The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b Yue-Zhi Lee, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, et al. (+8)
10 [GO] 2022―Jul―13 Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, et al. (+3)
11 [GO] 2022―Jul―07 Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters Allegra Peletta, Eakachai Prompetchara, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Nongnaphat Yostrerat, et al. (+8)
12 [GO] 2022―Jul―01 Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome Monica-Carolina Villa-Hermosilla, Sofia Negro, Emilia Barcia, Carolina Hurtado, Consuelo Montejo, Mario Alonso, Ana Fernandez-Carballido
13 [GO] 2022―May―30 Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection Valentina Ruggiero, Rita P. Aquino, Pasquale Del Gaudio, Pietro Campiglia, Paola Russo
14 [GO] 2022―May―21 Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants Cong Liu, Nino Rcheulishvili, Zhigao Shen, Dimitri Papukashvili, Fengfei Xie, Ziqian Wang, et al. (+3)
15 [GO] 2022―May―17 Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges Jasmin Hassan, Charlotte Haigh, Tanvir Ahmed, Md Jasim Uddin, Diganta B. Das
16 [GO] 2022―May―10 Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review Diego Fernández-Lázaro, Carlos Domínguez Ortega, Nerea Sánchez-Serrano, Fahd Beddar Chaib, David Jerves Donoso, Elena Jiménez-Callejo, Saray Rodríguez-García
17 [GO] 2022―Apr―19 Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2 Francisco Faísca, Vanessa Correia, Željko Petrovski, Luís C. Branco, Helena Rebelo-de-Andrade, Miguel M. Santos
18 [GO] 2022―Apr―14 Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, et al. (+6)
19 [GO] 2022―Apr―14 Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, et al. (+7)
20 [GO] 2022―Mar―14 Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study Ayman M. Al-Qaaneh, Fuad H. Al-Ghamdi, Sayed AbdulAzeez, J. Francis Borgio
21 [GO] 2022―Mar―07 COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments Ahmed Abdeen Hamed, Tamer E. Fandy, Karolina L. Tkaczuk, Karin Verspoor, Byung Suk Lee
22 [GO] 2022―Mar―01 Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger, et al. (+4)
23 [GO] 2022―Feb―28 Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic Nadezhda Ivanova, Yoana Sotirova, Georgi Gavrailov, Krastena Nikolova, Velichka Andonova
24 [GO] 2022―Feb―09 Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2 Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, et al. (+3)
25 [GO] 2022―Jan―28 Inhibition of Escherichia Virus MS2, Surrogate of SARS-CoV-2, via Essential Oils-Loaded Electrospun Fibrous Mats: Increasing the Multifunctionality of Antivirus Protection Masks Joana M. Domingues, Marta O. Teixeira, Marta A. Teixeira, David Freitas, Samira F. da Silva, Shafagh D. Tohidi, et al. (+6)
26 [GO] 2022―Jan―10 In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19 Anirudh Pratap Singh Raman, Kamlesh Kumari, Pallavi Jain, Vijay Kumar Vishvakarma, Ajay Kumar, Neha Kaushik, et al. (+3)
27 [GO] 2021―Dec―09 Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses Rosa Giugliano, Carmine Buonocore, Carla Zannella, Annalisa Chianese, Fortunato Palma Esposito, Pietro Tedesco, et al. (+4)
28 [GO] 2021―Nov―03 Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, et al. (+3)
29 [GO] 2021―Oct―25 Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial Mustafa Erelel, Mert Kaskal, Ozlem Akbal-Dagistan, Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci, et al. (+12)
30 [GO] 2021―Oct―22 A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19 Essa M. Saied, Yousra A. El-Maradny, Alaa A. Osman, Amira M. G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, et al. (+4)
31 [GO] 2021―Oct―12 Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection Jiapeng Li, Shuhan Liu, Jian Shi, Hao-Jie Zhu
32 [GO] 2021―Oct―09 Can the Nasal Cavity Help Tackle COVID-19? Bissera Pilicheva, Radka Boyuklieva
33 [GO] 2021―Sep―29 Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era Piers J. Naughton, Mary Joyce, Marc Mac Giolla Eain, Andrew O’Sullivan, Ronan MacLoughlin
34 [GO] 2021―Sep―22 Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities Yong Xiang, Kenneth Chi-Yin Wong, Hon-Cheong So
35 [GO] 2021―Sep―22 Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity Serge Mignani, Xiangyang Shi, Andrii Karpus, Giovanni Lentini, Jean-Pierre Majoral
36 [GO] 2021―Sep―18 Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, et al. (+4)
37 [GO] 2021―Sep―06 Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro Linda Brunotte, Shuyu Zheng, Angeles Mecate-Zambrano, Jing Tang, Stephan Ludwig, Ursula Rescher, Sebastian Schloer
38 [GO] 2021―Aug―23 Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients Federico Romano, Salvatore D’Agate, Oscar Della Pasqua
39 [GO] 2021―Aug―16 Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19 Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B. MacArthur, et al. (+2)
40 [GO] 2021―Aug―02 Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized? Jessica M. Conway, Pia Abel zur Wiesch
41 [GO] 2021―Jul―14 Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, Robin Polt, Julie G. Ledford, Heidi M. Mansour
42 [GO] 2021―Jul―07 Pre-Drawn Syringes of Comirnaty for an Efficient COVID-19 Mass Vaccination: Demonstration of Stability Francesca Selmin, Umberto M. Musazzi, Silvia Franzè, Edoardo Scarpa, Loris Rizzello, Patrizia Procacci, Paola Minghetti
43 [GO] 2021―May―31 A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19 Bárbara Costa, Nuno Vale
44 [GO] 2021―May―27 Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19 Kevin McCoy, Sateesh Gudapati, Lawrence He, Elaina Horlander, David Kartchner, Soham Kulkarni, et al. (+7)
45 [GO] 2021―May―24 Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone Monika Kadela-Tomanek, Maria Jastrzębska, Krzysztof Marciniec, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka
46 [GO] 2021―Apr―14 Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics Dan-Yang Liu, Jia-Chen Liu, Shuang Liang, Xiang-He Meng, Jonathan Greenbaum, Hong-Mei Xiao, et al. (+2)
47 [GO] 2021―Apr―07 Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, et al. (+8)
48 [GO] 2021―Apr―05 Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics Matteo Puccetti, Claudio Costantini, Maurizio Ricci, Stefano Giovagnoli
49 [GO] 2021―Apr―02 A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework Raul Pérez-Moraga, Jaume Forés-Martos, Beatriz Suay-García, Jean-Louis Duval, Antonio Falcó, Joan Climent
50 [GO] 2021―Mar―08 Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection Ana Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, Iria Varela-Rey, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, et al. (+24)
51 [GO] 2021―Feb―26 Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities Milo Gatti, Fabrizio De De Ponti
52 [GO] 2021―Feb―26 Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Aloafi, Ahmed Mostafa, et al. (+5)
53 [GO] 2020―Dec―22 Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier
54 [GO] 2020―Oct―05 COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics Saman Zafar, Muhammad Sohail Arshad, Sameen Fatima, Amna Ali, Aliyah Zaman, Elshaimaa Sayed, et al. (+2)
55 [GO] 2020―May―11 MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice Hye-Jung Kim, Hye Won Kwak, Kyung Won Kang, Yoo-Jin Bang, Yu-Sun Lee, Hyeong-Jun Park, et al. (+5)
 [1] 

55 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec